(Q48398015)

11 February 2018

title

Biomarkers of depression in cancer patients (English)

1 reference

11 February 2018

1 reference

Christian Friedrich Jehn

1

1 reference

11 February 2018

Dagmar Kuehnhardt

2

1 reference

11 February 2018

Andrea Bartholomae

3

1 reference

11 February 2018

Sebastian Pfeiffer

4

1 reference

11 February 2018

Michael Krebs

5

1 reference

11 February 2018

Anne Constanze Regierer

6

1 reference

11 February 2018

Peter Schmid

7

1 reference

11 February 2018

Kurt Possinger

8

1 reference

11 February 2018

Bernd Christian Flath

9

1 reference

11 February 2018

language of work or name

English

0 references

publication date

1 December 2006

1 reference

11 February 2018

number of pages

7

1 reference

inferred from page(s)

published in

Cancer

1 reference

11 February 2018

volume

107

1 reference

11 February 2018

issue

11

1 reference

11 February 2018

page(s)

2723-2729

1 reference

11 February 2018

The pathophysiologic roles of interleukin-6 in human disease

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22294

Serum interleukin-6 levels correlate with disease status in patients with epithelial ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22294

Depression in rheumatoid arthritis: a systematic review of the literature with meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22294

Association of interleukin-6 and other biologic variables with depression in older people living in the community

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22294

Effect of psychosocial treatment on survival of patients with metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22294

7 January 2021

Diurnal activity and pulsatility of the hypothalamus-pituitary-adrenal system in male depressed patients and healthy controls.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22294

7 January 2021

Elevated Concentrations of CSF Corticotropin-Releasing Factor-Like Immunoreactivity in Depressed Patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22294

7 January 2021

Serial assessment of corticotropin-releasing hormone response after dexamethasone in depression. Implications for pathophysiology of DST nonsuppression

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22294

7 January 2021

The combined dexamethasone/CRH test: a refined laboratory test for psychiatric disorders

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22294

7 January 2021

Prediction of medium-term outcome by cortisol response to the combined dexamethasone-CRH test in patients with remitted depression

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22294

7 January 2021

Cortisol response in the combined dexamethasone/CRH test as predictor of relapse in patients with remitted depression. a prospective study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22294

7 January 2021

HPA axis activation in major depression and response to fluoxetine: a pilot study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22294

7 January 2021

Indicators of immune activation in major depression

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22294

7 January 2021

Higher than normal plasma interleukin-6 concentrations in cancer patients with depression: preliminary findings

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22294

7 January 2021

Hydrocortisone regulation of interleukin-6 protein production by a purified population of human peripheral blood monocytes

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22294

7 January 2021

Decreased hypothalamic-pituitary-adrenal axis sensitivity to cortisol feedback inhibition in human aging.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22294

7 January 2021

Interleukin-6 and prostate cancer progression

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22294

7 January 2021

Interleukin-6 serum levels in patients with gynecological tumors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22294

7 January 2021

Measurement of depression in patients with cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22294

7 January 2021

The prevalence of psychiatric disorders among cancer patients.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22294

7 January 2021

Comparative studies of psychological function in patients with advanced cancer--I. Self-reported depressive symptoms

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22294

7 January 2021

Prevalence of depression in patients with cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22294

7 January 2021

The factor structure and factor stability of the hospital anxiety and depression scale in patients with cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22294

7 January 2021

The hospital anxiety and depression scale

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22294

7 January 2021

The prevalence and predictors of psychological distress in patients with early localized prostate cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22294

7 January 2021

Depression in patients with cardiac disease: a practical review

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22294

7 January 2021

Psychosocial factors and interleukin-6 among women with advanced ovarian cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22294

7 January 2021

Plasma concentrations of interleukin-1beta, interleukin-6, soluble interleukin-2 receptor and tumor necrosis factor alpha of depressed patients in Japan

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22294

7 January 2021

Effects of cytokines on glucocorticoid receptor expression and function. Glucocorticoid resistance and relevance to depression

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22294

7 January 2021

Increased serum IL-6 and IL-1 receptor antagonist concentrations in major depression and treatment resistant depression.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22294

7 January 2021

Pain characteristics and treatment in an outpatient cancer population

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22294

7 January 2021

Pharmacotherapy of depression in the medically ill: directions for future research

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22294

7 January 2021

Diagnosis of major depression in cancer patients according to four sets of criteria

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22294

7 January 2021

Screening for mental disorders in cancer, cardiovascular and musculoskeletal diseases. Comparison of HADS and GHQ-12.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22294

7 January 2021

Medication noncompliance: systematic approaches to evaluation and intervention

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22294

7 January 2021

Survival and health care utilization in elderly medical inpatients with major depression

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22294

7 January 2021

Identifiers

DOI

10.1002/CNCR.22294

1 reference

11 February 2018

1 reference

11 February 2018